Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,259.22
+0.8%
+58.47
Arrow-Thin-Down
DJI
49,298.25
+0.7%
+356.35
Arrow-Thin-Down
NASDAQ
25,326.13
+1.0%
+258.32
Arrow-Thin-Down
Bitcoin
$81,353.00
+0.5%
+$438.10
Arrow-Thin-Down
AAPL
$284.18
+2.7%
+$7.35
Arrow-Thin-Down
AMZN
$273.71
+0.6%
+$1.66
Arrow-Thin-Down
GOOG
$384.27
+1.2%
+$4.63
Arrow-Thin-Down
META
$605.00
-0.9%
-$5.41
Arrow-Thin-Down
MSFT
$411.39
-0.5%
-$2.23
Arrow-Thin-Down
NVDA
$196.45
-1.0%
-$2.03
Arrow-Thin-Down
TSLA
$389.76
-0.7%
-$2.75
Most Active StocksDaily Stock GainersDaily Stock Losers
Oragenics logo

Oragenics

(NYSEMKT) OGEN

Current Price$0.63
Market Cap$2.77M
Since IPO (2003)-100%
5 Year-100%
1 Year-87%
1 Month+14%

Oragenics Financials at a Glance

Market Cap

$2.77M

Revenue (TTM)

$0.00

Net Income (TTM)

$9.84M

EPS (TTM)

$-9.26

P/E Ratio

-0.07

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$0.63

Volume

40,654

Open

$0.62

Previous Close

$0.64

Daily Range

$0.61 - $0.65

52-Week Range

$0.50 - $9.60

OGEN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oragenics

Industry

Biotechnology

Sector

Health Care

Employees

3

CEO

Janet Huffman

Website

www.oragenics.com

Headquarters

Tampa, FL 33634, US

OGEN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-244%

Return on Capital

-1%

Return on Assets

-98%

Earnings Yield

-14.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.77M

Shares Outstanding

4.34M

Volume

40.65K

Avg. Volume

252.62K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.36M

EBITDA

$9.36M

Operating Cash Flow

$9.25B

Capital Expenditure

$3.00

Free Cash Flow

$9.25B

Cash & ST Invst.

$8.40M

Total Debt

$227.35M

Oragenics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.77M

N/A

Market Cap/Employee

$923.57K

N/A

Employees

3

N/A

Net Income

$2.29M

+31.7%

EBITDA

$2.50M

+25.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$218.95M

-40924.8%

Accounts Receivable

$53.08M

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$227.35M

+69102.0%

Return on Assets

-97.76%

N/A

Return on Invested Capital

-1.13%

N/A

Free Cash Flow

$2.84M

-40.5%

Operating Cash Flow

$2.84M

-40.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KALAKALA BIO, Inc.
$0.11+3.80%
TTNPTitan Pharmaceuticals, Inc.
$2.34-11.36%
SNGXSoligenix, Inc.
$0.32-7.80%
ENSCEnsysce Biosciences, Inc.
$0.40-4.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
DGXXDigi Power X
$5.11+0.29%
NOKNokia
$13.42+0.02%
CCLCarnival Corp.
$25.77+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.81+0.02%

Questions About OGEN

What is the current price of Oragenics?

Oragenics is trading at $0.64 per share.

What is the 52-week range for Oragenics?

Over the past 52 weeks, Oragenics has traded between $0.50 and $9.60.

How much debt does Oragenics have?

As of the most recent reporting period, Oragenics reported total debt of $227,348.

How much cash does Oragenics have on hand?

Oragenics reported $4.40M in cash and cash equivalents in its most recent financial results.

What is Oragenics’s dividend yield?

Oragenics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services